Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Mammoth Biosciences
Biotech
Regeneron signs Mammoth gene editing deal worth $100M upfront
Regeneron is signing another major deal in gene editing—and, this time, it’s Mammoth.
Annalee Armstrong
Apr 25, 2024 8:49am
'Riding a tiger' from lab to C-suite with Mammoth's Janice Chen
May 16, 2023 6:00am
Roche taps new North American diagnostics chief—Chutes & Ladders
Dec 9, 2022 9:30am
Baynes ditches Merck for CMO role at Eikon—Chutes and Ladders
Mar 25, 2022 9:30am
Mammoth gets green light for CRISPR-powered COVID test
Jan 24, 2022 3:33pm
JPM22, Day 1: Bayer strikes a Mammoth deal and more
Jan 10, 2022 4:25am
